BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15660840)

  • 1. Protein C, protein S, and antithrombin III in twice-frozen plasma.
    Sivakumaran M; Long S; Drury M
    Transfusion; 2005 Feb; 45(2):281. PubMed ID: 15660840
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
    El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
    Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of reduced levels of protein C, free protein S and antithrombin in normal frozen plasma on the interpretation of patients' results.
    Gupta AD; Sharma A
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):51-5. PubMed ID: 22089940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis in patients with fulminant hepatic failure.
    Mandell MS; Henthorn T
    Liver Transpl Surg; 1999 Sep; 5(5):464. PubMed ID: 10523124
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?
    Hsin Shieh H; Roseli Barreira E; Freitas Góes P; Bousso A; Ventura Brazilian GA; Melo AM; Ibidi SM
    Pediatr Crit Care Med; 2010 Nov; 11(6):767-8; author reply 768-9. PubMed ID: 21057275
    [No Abstract]   [Full Text] [Related]  

  • 7. Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with cutis marmorata.
    Li TH; Chen TH; Lin HS; Liou CW; Liu JS; Chen SS; Chen WH
    Acta Neurol Taiwan; 2008 Dec; 17(4):233-8. PubMed ID: 19280866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of thrombophilic abnormalities in Turkish children with inflammatory bowel disease.
    Saltik IN; Ozen H; Gürakan F; Yüce A; Koçak N
    Am J Gastroenterol; 2000 Sep; 95(9):2395. PubMed ID: 11007257
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombin III, protein C and protein S in children with chronic viral hepatitis B or C].
    Adamska I; Szaflarska-Szczepanik A; Chrobot A; Kulwas A; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2003; 7(2):289-97. PubMed ID: 12878800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation and physiological anticoagulants in sickle-cell disease.
    Bashawri LA; Al-Mulhim AA; Ahmed MA; Bahnassi AA
    East Mediterr Health J; 2007; 13(2):266-72. PubMed ID: 17684847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke].
    Oláh L; Csépány T; Bereczky Z; Kerényi A; Misz M; Kappelmayer J; Csiba L
    Ideggyogy Sz; 2005 Jan; 58(1-2):33-9. PubMed ID: 15884396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C, protein S and antithrombin III metabolism in dialysis patients.
    Lai KN
    Int J Artif Organs; 1993 Jan; 16(1):4-6. PubMed ID: 8458670
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of protein C, protein S, and antithrombin III in patients with subarachnoid haemorrhage.
    Kanamaru K; Waga S; Tanaka K
    Acta Neurochir (Wien); 1997; 139(2):134-40. PubMed ID: 9088371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activity levels and prevalence of deficiency of protein C, protein S and antithrombin in Chinese Han population].
    Zhu TN; Zhao YQ; Ding QL; Bai X; Wang XY; Wang XF; Yang RC; Wang ZY; Hua BL; Wel XQ; Ruan CG; Schlegel N
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):127-30. PubMed ID: 22730664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia in young patients with acute myocardial infarction.
    Celik M; Altintas A; Celik Y; Karabulut A; Ayyildiz O
    Saudi Med J; 2008 Jan; 29(1):48-54. PubMed ID: 18176672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between anti-coagulation system changes of coronary heart disease patients and different syndrome-type in TCM].
    Liang TJ; Gao SZ; Zhang FL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):599-600. PubMed ID: 8704425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance in cord blood from healthy and complicated newborns.
    Gursel T; Kocak U; Kaya Z; Bukulmez A; Atalay Y
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):797-801. PubMed ID: 17853185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.